TGFB1 and neoplasm: Since these dnTβRII cells do not respond to TGF-β signaling exhibit TGF-β-mediated signaling, any increase in proliferation, activation, or cytokine production observed in the TGF-βRII CAR T cells can be attributed to CAR-mediated responses rather than TGF-β’s broader tumor-promoting effects.